End-of-day quote
Shanghai S.E.
06:00:00 2024-05-19 pm EDT
|
5-day change
|
1st Jan Change
|
36.32
CNY
|
+2.77%
|
|
+0.55%
|
-29.73%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,745
|
3,703
|
11,131
|
6,593
|
4,302
|
3,028
|
-
|
-
|
Enterprise Value (EV)
1 |
2,745
|
3,703
|
11,131
|
6,593
|
4,302
|
3,028
|
3,028
|
3,028
|
P/E ratio
|
24.6
x
|
29.1
x
|
40.6
x
|
33.2
x
|
30.1
x
|
16.3
x
|
8.56
x
|
11.3
x
|
Yield
|
-
|
1.09%
|
0.78%
|
0.9%
|
1.16%
|
2.92%
|
3.72%
|
-
|
Capitalization / Revenue
|
6.76
x
|
8.2
x
|
12.7
x
|
7.72
x
|
4.42
x
|
2.7
x
|
1.87
x
|
2.21
x
|
EV / Revenue
|
6.76
x
|
8.2
x
|
12.7
x
|
7.72
x
|
4.42
x
|
2.7
x
|
1.87
x
|
2.21
x
|
EV / EBITDA
|
-
|
21.8
x
|
33.2
x
|
24.6
x
|
18.3
x
|
9.43
x
|
6.59
x
|
6.35
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.8
x
|
9.09
x
|
4.26
x
|
2.6
x
|
1.58
x
|
1.35
x
|
1.32
x
|
Nbr of stocks (in thousands)
|
80,948
|
80,948
|
81,191
|
83,230
|
83,230
|
83,382
|
-
|
-
|
Reference price
2 |
33.91
|
45.74
|
137.1
|
79.21
|
51.69
|
36.32
|
36.32
|
36.32
|
Announcement Date
|
2/24/20
|
2/17/21
|
2/25/22
|
2/14/23
|
2/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
406
|
451.6
|
877.6
|
853.8
|
972.2
|
1,123
|
1,624
|
1,371
|
EBITDA
1 |
-
|
169.9
|
335.7
|
268.5
|
234.8
|
321
|
459.7
|
477
|
EBIT
1 |
-
|
147.1
|
303.3
|
223.9
|
176.2
|
211
|
400.8
|
305
|
Operating Margin
|
-
|
32.58%
|
34.55%
|
26.23%
|
18.13%
|
18.78%
|
24.69%
|
22.25%
|
Earnings before Tax (EBT)
1 |
-
|
148.3
|
317.8
|
215.7
|
174.7
|
211
|
399.7
|
305
|
Net income
1 |
-
|
127.4
|
275.4
|
197.9
|
153
|
186
|
352.9
|
268.2
|
Net margin
|
-
|
28.21%
|
31.38%
|
23.17%
|
15.74%
|
16.56%
|
21.74%
|
19.56%
|
EPS
2 |
1.379
|
1.571
|
3.379
|
2.386
|
1.720
|
2.230
|
4.244
|
3.220
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.5000
|
1.071
|
0.7143
|
0.6000
|
1.060
|
1.350
|
-
|
Announcement Date
|
2/24/20
|
2/17/21
|
2/25/22
|
2/14/23
|
2/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
13.9%
|
24.2%
|
13.9%
|
9.06%
|
15.1%
|
17.2%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
10.9%
|
19.2%
|
10.1%
|
-
|
6.3%
|
9.55%
|
8%
|
Assets
1 |
-
|
1,170
|
1,432
|
1,951
|
-
|
2,953
|
3,696
|
3,352
|
Book Value Per Share
2 |
-
|
12.00
|
15.10
|
18.60
|
19.90
|
23.00
|
26.80
|
27.40
|
Cash Flow per Share
2 |
-
|
1.570
|
4.760
|
-0.3900
|
-1.170
|
2.920
|
6.160
|
-
|
Capex
1 |
-
|
95.2
|
286
|
184
|
104
|
250
|
304
|
300
|
Capex / Sales
|
-
|
21.09%
|
32.6%
|
21.5%
|
10.68%
|
22.25%
|
18.7%
|
21.89%
|
Announcement Date
|
2/24/20
|
2/17/21
|
2/25/22
|
2/14/23
|
2/24/24
|
-
|
-
|
-
|
Last Close Price
36.32
CNY Average target price
54.5
CNY Spread / Average Target +50.06% Consensus |
1st Jan change
|
Capi.
|
---|
| -29.73% | 419M | | +4.72% | 105B | | -6.35% | 62.52B | | +72.86% | 49.08B | | +16.94% | 38.99B | | +5.28% | 32.59B | | +14.48% | 20.6B | | +15.10% | 17.19B | | +18.07% | 15.13B | | +4.83% | 14.36B |
Other Commodity Chemicals
|